Corrigendum to “Transferrin-guided intelligent nanovesicles augment the targetability and potency of clinical PLK1 inhibitor to acute myeloid leukemia” [Bioact. Mater. 21 (March 2023) 499-510]

Bioact Mater. 2023 Aug 21;31:312-314. doi: 10.1016/j.bioactmat.2023.08.011. eCollection 2024 Jan.


[This corrects the article DOI: 10.1016/j.bioactmat.2022.08.032.].

PMID:37637085 | PMC:PMC10458256 | DOI:10.1016/j.bioactmat.2023.08.011


Related Posts

Leave a Reply

Your email address will not be published. Required fields are marked *